Chronic Kidney Disease
The medications are associated with reduced odds of kidney failure and death compared with angiotensin II receptor blockers.
CKD progression from stage 3 to stage 4 also was associated with increased risks of acute kidney injury and hospitalization.
Patients treated with the uric acid-lowering drug were less likely to experience a greater than 10% decline in eGFR than placebo recipients.
Left ventricular hypertrophy is associated with a 4.5 times increased risk of rapid kidney function decline.
A low protein diet of vegetable proteins along with reduced intake of specific micronutrients should be recommended to stage 3-4 CKD patients, researchers say.
As of 2014, rate is 16.8% but big socioeconomic disparities remain.
Each standard deviation increment in pulse pressure and pulse wave velocity is associated with an 11% and 7% increased risk of CKD, respectively.
Long-term statin treatment cut the rates of major adverse cardiovascular events by 20.5%, all-cause mortality by 28.6%.
Researchers also observe an increased risk of early death from any cause.
Personalized medications based on a patient's medical and biological profiles may be possible with 3D printing.
Greater frequency of attending appointments; no difference in the incidence of composite outcomes.
Five hours or less a night linked to reduced organ function in women.
It develops in 8% of patients overall and 15.1% of patients with stage 5 CKD.
The risk of dying following a hip fracture was 6.5 times higher for patients with severe CKD than for those with normal kidney function or mild CKD.
High levels of soluble urokinase-type plasminogen activator receptor are associated with an elevated CKD risk in individuals with normal eGFR.
Iron deficiency may contribute to the relationship between proteinuria and excess FGF-23, researchers suggested.
It also may be more effective at lowering parathyroid hormone levels compared with conventional dosing.
Researchers observe an increased risk of a composite outcome of death from any cause and cardiovascular events.
The odds of major adverse cardiac events were 46% to 76% higher in anemic vs. non-anemic patients.
Based on these groupings, physicians can provide more individualized treatment.
But studies weren't designed to prove proton pump inhibitors are responsible for the increase.
Study found awareness of thoughts and feelings was linked to lower risk for obesity.
RED-HF study confirms the increased stroke risk observed in TREAT.
Patiromer for oral suspension lowers potassium levels in hyperkalemic patients with chronic kidney disease.
CKD patients seen by both PCPs and nephrologists had better monitoring for progression and complications.
Stroke patients with CKD had greater risks of symptomatic intracerebral hemorrhage and early death compared with non-CKD patients.
In a study, investigators found 70% adherence to the diet, which recommended not adding salt during cooking or at the table.
Successfully treating anemia in pre-dialysis CKD patients appears to prevent left ventricular remodeling.
Declines in 2 of 7 recommendations: imaging for headache and cardiac imaging for low-risk patients.
Besides hypertension and diabetes, 'discordant' co-existing illnesses as chronic pulmonary disease predict adverse outcomes.
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)